Sonnet BioTherapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Long-Term Debt and Notes Payable - Summary of Long-Term Debt and Notes Payable (Details) (Parenthetical)

Long-Term Debt and Notes Payable - Summary of Long-Term Debt and Notes Payable (Details) (Parenthetical) - USD ($)			1 Months Ended			12 Months Ended
	May 04, 2017	May 04, 2017	Oct. 31, 2017	Mar. 31, 2017	Feb. 28, 2017	Dec. 31, 2017	Dec. 31, 2016	Oct. 12, 2017
Warrant exercise price per share	$ 3.50	$ 3.50
Proceeds from long term debt						$ 6,578,090	$ 275,000
Long term debt						5,741,911	6,459,094
Debt discount amortized value						$ 788,187	$ 1,039,656
Note One [Member]
Debt instruments bears interest rate						5.50%	5.50%
Convertible secured debentures principal balance						$ 36,502	$ 36,502
Note payable maturity date						Sep. 10, 2018	Sep. 10, 2018
Debt periodic payment						$ 4,406	$ 4,406
Note Two [Member]
Debt instruments bears interest rate						5.25%	5.25%
Convertible secured debentures principal balance						$ 199,992	$ 199,992
Note payable maturity date						May 10, 2019	May 10, 2019
Debt periodic payment						$ 11,532	$ 11,532
Note Three [Member]
Debt instruments bears interest rate						5.25%	5.25%
Convertible secured debentures principal balance						$ 335,782	$ 335,782
Note payable maturity date						Aug. 10, 2021	Aug. 10, 2021
Debt periodic payment						$ 8,500	$ 8,500
Note [Member]
Convertible secured debentures principal balance						572,276	572,276
Debt periodic payment						24,438	$ 24,438
Mortgage Note [Member]
Proceeds from sale of property						6,000,000
USD [Member] \| Mortgage Note [Member]
Proceeds from sale of property						470,000
Daily Payment [Member]
Debt periodic payment			$ 1,200
Lender [Member]
Convertible secured debentures principal balance						$ 3,000,000
Note payable maturity date						Jun. 30, 2018
Proceeds from long term debt				$ 150,000	$ 330,000
Lender [Member] \| 210 days [Member]
Debt periodic payment					$ 1,965
Lender [Member] \| 240 days [Member]
Debt periodic payment						$ 856
Florida Mezzanine [Member]
Payment for exchange						$ 5,000,000
Agreement description						The Company from all claims and outstanding obligations pursuant to that certain Assumption Agreement dated September 30, 2014, as amended October 15, 2014 and October 22, 2016, and that certain Agreement dated May 23, 2016, as amended January 30, 2017, in exchange for payment of $5,000,000.
Proceeds from long term debt						$ 500,000
Long term debt						206,746
Proceeds from restricted cash						165,517
Note payable						5,000,000
Loss on extinguishment of debt						95,310
Additional paid in capital warrant issued						1,700,000
Debt origination costs						300,000
Debt discount amortized value						2,000,000
Florida Mezzanine [Member] \| Loan [Member]
Long term debt						6,000,000
Paragon Bank [Member] \| Loan [Member]
Note payable						$ 75,000
Number of restricted stock shares issued						800
Securities Purchase Agreement [Member]
Debt instruments bears interest rate	8.00%	8.00%
Convertible secured debentures principal balance	$ 6,000,000	$ 6,000,000
Number of warrant to purchase shares of common stock	1,200,000	1,200,000
Warrant exercise price per share								$ 3.50
Securities Purchase Agreement [Member] \| Warrants [Member]
Reverse stock split	one-for-ten reverse stock split
Note payable maturity date	Dec. 31, 2018
Sale of assets trigger percentage	33.00%
Demand repayment	108.00%
Securities Purchase Agreement [Member] \| Warrants One [Member]
Number of warrant to purchase shares of common stock	800,000	800,000
Aggregate purchase price	$ 6,500,000	$ 6,500,000
Warrant exercise price per share	$ 3.50	$ 3.50
Beneficial ownership limit, percentage		4.99%
Securities Purchase Agreement [Member] \| Warrants Two [Member]
Number of warrant to purchase shares of common stock	400,000	400,000
Beneficial ownership limit, percentage	19.99%
Non-Binding Agreement [Member]
Asset impairment loss						$ 823,000